1. Stocks
    2. /
  2. CSL (ASX: CSL)
    3. /

CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • CSL (ASX: CSL)
    Latest News

    A couple sit on the deck of a yacht with a beautiful mountain and lake backdrop enjoying the fruits of their long-term ASX shares and dividend income.
    Retirement

    Buy these high-quality ASX 200 shares for your retirement portfolio

    | James Mickleboro

    Here's why Goldman Sachs is bullish on these top shares.

    Read more »

    A group of young ASX investors sitting around a laptop with an older lady standing behind them explaining how investing works.
    Growth Shares

    10 ASX shares I would buy in 2024

    | James Mickleboro

    Here's where I would put my money during the next 12 months.

    Read more »

    a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
    Broker Notes

    Brokers name 3 ASX shares to buy now

    | James Mickleboro

    Here's why brokers are feeling bullish about these three shares.

    Read more »

    Woman flexes muscles after donating blood.
    Broker Notes

    3 ASX 200 buy-the-dip opportunities recommended by brokers today

    | Bronwyn Allen

    Here are three ASX 200 shares that brokers say are buys following share price tumbles or stagnation in 2023.

    Read more »

    A woman in a sparkly dress smiles knowingly as she holds up two blue casino gambling chips in her hand next to her face.
    Blue Chip Shares

    Buy these strong blue chip ASX 200 shares now: analysts

    | James Mickleboro

    Brokers are saying good things about these blue chips.

    Read more »

    Middle age caucasian man smiling confident drinking coffee at home.
    Healthcare Shares

    Are CSL shares good value at current prices?

    | James Mickleboro

    Is this blue chip a star buy for 2024? Let's see what analysts are saying.

    Read more »

    A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
    Blue Chip Shares

    3 outstanding blue chip ASX 200 shares to buy in 2024

    | James Mickleboro

    Analysts have put buy ratings on these blue chips.

    Read more »

    Person handing out $50 notes, symbolising ex-dividend date.
    Dividend Investing

    Want extra monthly cash? One ASX dividend stock to buy now and hold forever

    | James Mickleboro

    A leading broker is very bullish on the long-term outlook for this share.

    Read more »

    Medical or healthcare workers grasp hands in the universal expression of teamwork
    Healthcare Shares

    Interested in CSL shares? This could be the 'next catalyst'

    | Tristan Harrison

    Is the huge biotech stock a big opportunity?

    Read more »

    A skydiving man in a jester hat and carrying a burger and sauce, pokes out his tongue at the camera, indicating all is not lost when you're falling.
    Cheap Shares

    5 oversold ASX shares to buy before the end of 2023

    | Motley Fool Staff

    Hoping to cap off the year with a great-value investment?

    Read more »

    In the lab at work, the mature adult woman and young adult man smile as they review the results of their successful experimentation.
    Healthcare Shares

    What is the outlook for ASX healthcare shares in 2024?

    | Tristan Harrison

    Can things get better in 2024?

    Read more »

    Couple looking at their phone surprised, symbolising a bargain buy.
    Healthcare Shares

    How big could the return be with CSL shares in 2024?

    | James Mickleboro

    Could this biotech company be a market beater in 2024?

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note